Is Valbiotis SA halal to invest in?

According to Musaffa's Shariah screening methodology, Valbiotis SA (ALVAL.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Valbiotis SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Valbiotis SA using these criteria to determine its compliance status.

Can Muslims buy shares of Valbiotis SA?

Muslim investors may consider investing in Valbiotis SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Valbiotis SA classified as NOT HALAL?

Musaffa determines the Shariah status of Valbiotis SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Valbiotis SA updated?

The Shariah compliance status of Valbiotis SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Valbiotis SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Valbiotis SA?

You can check the latest Shariah compliance status of Valbiotis SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Valbiotis SA ALVAL.PA

€1.22

Last Updated: May 15, 12:00 AM·XPAR

ALVAL.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Analyst's Ratings for Valbiotis SA (ALVAL.PA)

Based on 11 analysts giving stock ratings to Valbiotis SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valbiotis SA. Stock Analysis ALVAL.PA

France Health Care Nano Cap Report: 2024 Annual

Valbiotis SA engages in the products and candidate drugs designed to prevent metabolic diseases. The company employs 50 full-time employees The company went IPO on 2017-06-07. The firm specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. The company seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The firm prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. The company provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.

Key Statistics of Valbiotis SA (ALVAL.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.22€1.22

Today's Open

€1.22

Volume

1.00

P/E Ratio (TTM)

52 Week Range

€0.54€1.30

Market Cap

22.03M

Avg. Volume

76.75K

Dividend Yield

Financial Metrics & Statements of Valbiotis SA (ALVAL.PA)

FAQ's for Valbiotis SA (ALVAL.PA)

According to Musaffa’s Shariah screening methodology, Valbiotis SA (ALVAL.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.